MELBOURNE, Australia and INDIANAPOLIS, April 28, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces an educational webinar exploring the evolution of PSMA[1] ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) announces an educational webinar exploring the evolution of PSMA1-targeted radionuclide therapy and ...
Gosatomnadzor has found no excess of radionuclides in water or food in the contaminated zone in recent years, First Deputy ...
Expert Nikolay Kovalev added that by 2056, plutonium-241 will account only for 3.3% of the amount released into the environment, and its prevalence will decrease ...
aDivision of Human Health, Department of Nuclear Safety and Security, International Atomic Energy Agency, Vienna, Austria bDivision of Physical and Chemical Sciences, Department of Nuclear Safety and ...
Since the inception of radionuclide therapies by John Lawrence and Saul Hertz over 80 y ago, little has changed regarding dosing strategies. We tend to use empirical amounts of therapeutic ...